BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2461 related articles for article (PubMed ID: 7962038)

  • 1. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
    Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
    J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells.
    Ohe Y; Podack ER; Olsen KJ; Miyahara Y; Ohira T; Miura K; Nishio K; Saijo N
    Int J Cancer; 1993 Feb; 53(3):432-7. PubMed ID: 8428797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline.
    Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
    Gene Ther; 1994 Jul; 1(4):269-75. PubMed ID: 7584091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.
    Hollingsworth SJ; Darling D; Gäken J; Hirst W; Patel P; Kuiper M; Towner P; Humphreys S; Farzaneh F; Mufti GJ
    Br J Cancer; 1996 Jul; 74(1):6-15. PubMed ID: 8679459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection.
    Hara I; Nguyen H; Takechi Y; Gansbacher B; Chapman PB; Houghton AN
    Int J Cancer; 1995 Apr; 61(2):253-60. PubMed ID: 7705956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
    Kim TS; Cohen EP
    Cancer Res; 1994 May; 54(10):2531-5. PubMed ID: 8168073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
    Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
    J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
    Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
    Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
    Grangeon C; Cormary C; Douin-Echinard V; Favre G; Couderc B; Tilkin-Mariamé AF
    Cancer Gene Ther; 2002 Mar; 9(3):282-8. PubMed ID: 11896445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
    Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
    Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
    Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
    Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma].
    Ohira T; Ohe Y; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():48-51. PubMed ID: 1306238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.
    Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN
    Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoattractive effect on the effector cells of the supernatants from melanoma cells transfected with the interleukin-2 (IL-2), IL-4 or IL-6 gene.
    Cao X; Chen G; He L; Zhang W; Yu Y; Ye TX
    J Cancer Res Clin Oncol; 1998; 124(2):88-92. PubMed ID: 9654191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation.
    Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
    J Invest Dermatol; 2002 Sep; 119(3):541-8. PubMed ID: 12230493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors.
    Cao X; Chen C; Zhang W; Tao Q; Yu Y; Ye T
    Gene Ther; 1996 May; 3(5):421-6. PubMed ID: 9156803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.
    Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS
    Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The experimental study of expression of IL-2 cDNA in human bladder tumor cell and its biological behaviors].
    Jin F; Yu M; Hui H
    Zhonghua Wai Ke Za Zhi; 1996 Feb; 34(2):110-2. PubMed ID: 9388337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 124.